Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kos files sNDA for new Niaspan CF range of products

July 14, 2006

Abbott reports on a new AMPK activator for type 2 diabetes and the metabolic syndrome

July 14, 2006

Pharmacokinetic study shows feasibility of teriparatide nasal spray in the elderly

July 14, 2006

CJC-1295 normalizes body weight and length parameters in a mouse model of GH deficiency

July 13, 2006

New possible treatments for metabolic disorders described in recent patents

July 13, 2006

Recent patents describe new therapeutic agents for diabetes

July 13, 2006

Neose updates NE-180 progress

July 13, 2006

Ricerca BioSciences, new development partner for PhytoMedical's BDC-03

July 13, 2006

BIM-28125: new ghrelin agonist improves glucocorticosteroid catabolic effects

July 13, 2006

Avandamet approved for initial treatment of type 2 diabetes

July 12, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...